Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Lilienfeld

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
CNS Drug Reviews|August 15, 2002
Galantamine--a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's diseaseSean Lilienfeld
Journal of the Neurological Sciences|November 6, 2002
Relevant clinical outcomes in probable vascular dementia and Alzheimer's disease with cerebrovascular diseaseJohn O'Brien, Sean Lilienfeld
Dementia and Geriatric Cognitive Disorders|October 16, 2003
Management of patients with Alzheimer's disease plus cerebrovascular disease: 12-month treatment with galantamineRoger Bullock, Timo Erkinjuntti, Sean Lilienfeld, et al.
CNS Drugs|September 10, 2003
Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular diseaseGary Small, Timo Erkinjuntti, Alexander Kurz, et al.
Sleep|August 27, 2003
Sleep-related outcomes in persons with mild to moderate Alzheimer disease in a placebo-controlled trial of galantamineJeffrey S Markowitz, Elane M Gutterman, Sean Lilienfeld, et al.
Neuromodulation : Journal of the International Neuromodulation Society|December 14, 2011
The use of implanted programmable infusion pumps in the management of nonmalignant, chronic low-back painPeter Staats, Michael Whitworth, Mark Barakat, et al.
Lancet (London, England)|April 20, 2002
Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trialTimo Erkinjuntti, Alexander Kurz, Serge Gauthier, et al.
Clinical Therapeutics|July 16, 2003
An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementiaTimo Erkinjuntti, Alexander Kurz, Gary W Small, et al.
Journal of Neurosurgery. Pediatrics|September 3, 2011
Cerebrospinal shunt infection in patients receiving antibiotic-impregnated versus standard shuntsScott L Parker, William N Anderson, Sean Lilienfeld, et al.
Neurosurgery|August 4, 2010
A nonradiographic system for assessing pressure for the Codman-Hakim Programmable ValveNancy Olsen Bailey, Mark Luciano, Michael V Ward, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
CNS Drug Reviews|August 15, 2002
Galantamine--a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's diseaseSean Lilienfeld
Journal of the Neurological Sciences|November 6, 2002
Relevant clinical outcomes in probable vascular dementia and Alzheimer's disease with cerebrovascular diseaseJohn O'Brien, Sean Lilienfeld
Dementia and Geriatric Cognitive Disorders|October 16, 2003
Management of patients with Alzheimer's disease plus cerebrovascular disease: 12-month treatment with galantamineRoger Bullock, Timo Erkinjuntti, Sean Lilienfeld, et al.
CNS Drugs|September 10, 2003
Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular diseaseGary Small, Timo Erkinjuntti, Alexander Kurz, et al.
Sleep|August 27, 2003
Sleep-related outcomes in persons with mild to moderate Alzheimer disease in a placebo-controlled trial of galantamineJeffrey S Markowitz, Elane M Gutterman, Sean Lilienfeld, et al.
Neuromodulation : Journal of the International Neuromodulation Society|December 14, 2011
The use of implanted programmable infusion pumps in the management of nonmalignant, chronic low-back painPeter Staats, Michael Whitworth, Mark Barakat, et al.
Lancet (London, England)|April 20, 2002
Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trialTimo Erkinjuntti, Alexander Kurz, Serge Gauthier, et al.
Clinical Therapeutics|July 16, 2003
An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementiaTimo Erkinjuntti, Alexander Kurz, Gary W Small, et al.
Journal of Neurosurgery. Pediatrics|September 3, 2011
Cerebrospinal shunt infection in patients receiving antibiotic-impregnated versus standard shuntsScott L Parker, William N Anderson, Sean Lilienfeld, et al.
Neurosurgery|August 4, 2010
A nonradiographic system for assessing pressure for the Codman-Hakim Programmable ValveNancy Olsen Bailey, Mark Luciano, Michael V Ward, et al.
Pageof 2